Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort

BACKGROUND: The standard of care for newly diagnosed glioblastoma is maximal safe surgical resection, followed by chemoradiation therapy. We assessed carmustine wafer implantation efficacy and safety when used in combination with standard care. METHODS: Included were adult patients with (n = 354, im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Pallud, Johan, Audureau, Etienne, Noel, Georges, Corns, Robert, Lechapt-Zalcman, Emmanuèle, Duntze, Julien, Pavlov, Vladislav, Guyotat, Jacques, Hieu, Phong Dam, Le Reste, Pierre-Jean, Faillot, Thierry, Litre, Claude-Fabien, Desse, Nicolas, Petit, Antoine, Emery, Evelyne, Voirin, Jimmy, Peltier, Johann, Caire, François, Vignes, Jean-Rodolphe, Barat, Jean-Luc, Langlois, Olivier, Dezamis, Edouard, Parraga, Eduardo, Zanello, Marc, Nader, Edmond, Lefranc, Michel, Bauchet, Luc, Devaux, Bertrand, Menei, Philippe, Metellus, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633930/
https://ncbi.nlm.nih.gov/pubmed/26185110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov126
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados